<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ijms</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Molecular Sciences</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Int. J. Mol. Sci.</abbrev-journal-title>
        <abbrev-journal-title abbrev-type="pubmed">International Journal of Molecular Sciences</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">1422-0067</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/ijms18071421</article-id>
      <article-id pub-id-type="publisher-id">ijms-18-01421</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lipotoxicity-Induced PRMT1 Exacerbates Mesangial Cell Apoptosis via Endoplasmic Reticulum Stress</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Min-Jung</given-names>
          </name>
          <xref rid="af1-ijms-18-01421" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Ho Jae</given-names>
          </name>
          <xref rid="af2-ijms-18-01421" ref-type="aff">2</xref>
          <xref rid="af3-ijms-18-01421" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Dong-il</given-names>
          </name>
          <xref rid="af4-ijms-18-01421" ref-type="aff">4</xref>
          <xref rid="c1-ijms-18-01421" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-ijms-18-01421"><label>1</label>Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; <email>minjunp@med.umich.edu</email></aff>
      <aff id="af2-ijms-18-01421"><label>2</label>Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Korea; <email>hjhan@snu.ac.kr</email></aff>
      <aff id="af3-ijms-18-01421"><label>3</label>BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National University, Seoul 08826, Korea</aff>
      <aff id="af4-ijms-18-01421"><label>4</label>Life Science Institutes, University of Michigan, Ann Arbor, MI 48109, USA</aff>
      <author-notes>
        <corresp id="c1-ijms-18-01421"><label>*</label>Correspondence: <email>dongil@umich.edu</email>; Tel.: +1-734-834-5289; Fax: +1-734-615-5520</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>07</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">        <month>07</month>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>7</issue>
      <elocation-id>1421</elocation-id>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>06</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>06</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2017 by the authors.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access">
          <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Lipotoxicity-induced mesangial cell apoptosis is implicated in the exacerbation of diabetic nephropathy (DN). Protein arginine methyltransferases (PRMTs) have been known to regulate a variety of biological functions. Recently, it was reported that PRMT1 expression is increased in proximal tubule cells under diabetic conditions. However, their roles in mesangial cells remain unexplored. Thus, we examined the pathophysiological roles of PRMTs in mesangial cell apoptosis. Treatment with palmitate, which mimics cellular lipotoxicity, induced mesangial cell apoptosis via protein kinase RNA-like endoplasmic reticulum kinase (PERK) and ATF6-mediated endoplasmic reticulum (ER) stress signaling. Palmitate treatment increased PRMT1 expression and activity in mesangial cells as well. Moreover, palmitate-induced ER stress activation and mesangial cell apoptosis was diminished by PRMT1 knockdown. In the mice study, high fat diet-induced glomerular apoptosis was attenuated in PRMT1 haploinsufficient mice. Together, these results provide evidence that lipotoxicity-induced PRMT1 expression promotes ER stress-mediated mesangial cell apoptosis. Strategies to regulate PRMT1 expression or activity could be used to prevent the exacerbation of DN.</p>
      </abstract>
      <kwd-group>
        <kwd>PRMT1</kwd>
        <kwd>lipotoxicity</kwd>
        <kwd>mesangial cell</kwd>
        <kwd>apoptosis</kwd>
        <kwd>ER stress</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-ijms-18-01421" sec-type="intro">
      <title>1. Introduction</title>
      <p>Diabetic nephropathy (DN), one of the main causes of chronic kidney disease, is developed by 30&#x2013;40% of diabetic patients, making it one of the most common complications of diabetes [<xref ref-type="bibr" rid="B1-ijms-18-01421">1</xref>]. The development of DN is characterized by hypertrophy of the basement membrane of the glomerulus, which gradually becomes hypertrophic. Mesangial cells are the principal component of the glomerular mesangium, and, upon glomerular hypertrophy, the number of mesangial cells is increased, correlating with an increase in albumin excretion rate [<xref ref-type="bibr" rid="B2-ijms-18-01421">2</xref>]. However, during the progression to overt nephropathy, mesangial cells are lost via apoptosis, leading to renal dysfunction [<xref ref-type="bibr" rid="B3-ijms-18-01421">3</xref>,<xref ref-type="bibr" rid="B4-ijms-18-01421">4</xref>]. Multiple pathogenic mechanisms have been implicated in the development of DN, including hyperglycemia, oxidative stress, cytokines, and genetic susceptibility [<xref ref-type="bibr" rid="B5-ijms-18-01421">5</xref>]. One important mechanism implicated in DN is lipotoxicity or the accumulation of excess long-chain fatty acids in cells other than adipocytes [<xref ref-type="bibr" rid="B6-ijms-18-01421">6</xref>,<xref ref-type="bibr" rid="B7-ijms-18-01421">7</xref>]. It is known that mesangial cells are susceptible to lipotoxicity, and lipotoxicity-induced apoptosis of mesangial cells has been implicated in the development of renal failure [<xref ref-type="bibr" rid="B8-ijms-18-01421">8</xref>,<xref ref-type="bibr" rid="B9-ijms-18-01421">9</xref>]. However, the mechanism by which lipotoxicity induces apoptosis in these cells is not yet well understood.</p>
      <p>Endoplasmic reticulum stress (ER stress) is a physiological and pathological response to the excessive accumulation of unfolded or misfolded proteins in the ER. ER stress has been implicated in mediating lipotoxicity-induced apoptosis in multiple cell types, including renal proximal cells [<xref ref-type="bibr" rid="B10-ijms-18-01421">10</xref>,<xref ref-type="bibr" rid="B11-ijms-18-01421">11</xref>]. The ER stress pathway is mediated through three major proteins, protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6 (ATF6) [<xref ref-type="bibr" rid="B12-ijms-18-01421">12</xref>]. PERK is activated by autophosphorylation in response to the detection of misfolded proteins; in turn, it phosphorylates eukaryotic inhibition factor &#x3B1; (eIF2a), leading to an increase in the expression of apoptotic genes such as CCAAT-enhancer binding protein homologous protein (CHOP). IRE1 is an endoribonuclease that, upon activation by autophosphorylation, carries out the unconventional splicing of X-box binding protein-1 (XBP1) mRNA. Finally, the proteolytic cleavage of ATF6 by S1P and S2P in the Golgi allows the cytoplasmic subunit p50ATF6 to translocate to the nucleus and act as a transcription factor.</p>
      <p>Protein arginine methyltransferases (PRMTs) are enzymes that catalyze the methylation of arginine residues. In mammals, nine PRMTs (PRMT1-9) exist, and they are subdivided into three types according to the manner of methylation. Type I PRMTs (PRMT1, 2, 3, 4, 6, 8) catalyze the asymmetric dimethylation of substrates, while type II PRMTs (PRMT5, 9) catalyze symmetric dimethylation and type III PRMT (PRMT7) catalyzes monomethylation [<xref ref-type="bibr" rid="B13-ijms-18-01421">13</xref>]. Increased PRMT1 expression in proximal tubule cells has been reported to be critical to the progression of diabetic nephropathy [<xref ref-type="bibr" rid="B14-ijms-18-01421">14</xref>]. However, the regulatory and functional roles of PRMTs in mesangial cell apoptosis remain unexplored.</p>
      <p>Previously, we reported that lipotoxicity is observed in mesangial cells under diabetic conditions [<xref ref-type="bibr" rid="B15-ijms-18-01421">15</xref>]. We also recently reported that palmitate treatment, which mimics lipotoxicity, impairs hepatocyte function through the expression of PRMT1 and PRMT3 [<xref ref-type="bibr" rid="B16-ijms-18-01421">16</xref>,<xref ref-type="bibr" rid="B17-ijms-18-01421">17</xref>]. However, the role of PRMTs in mesangial cell apoptosis has not yet been evaluated. Thus, in this study, we have subjected cultured rat mesangial cells to a palmitate challenge and fed a high fat diet to mice to induce lipotoxicity in order to elucidate the role of PRMTs in lipotoxicity-induced mesangial cell apoptosis and the pathogenesis of diabetic nephropathy.</p>
    </sec>
    <sec id="sec2-ijms-18-01421" sec-type="results">
      <title>2. Results</title>
      <sec id="sec2dot1-ijms-18-01421">
        <title>2.1. Lipotoxicity Induces Mesangial Cell Apoptosis via PERK and ATF6 Signaling Pathways</title>
        <p>Palmitate-mediated lipotoxicity is known to induce mesangial cell apoptosis [<xref ref-type="bibr" rid="B8-ijms-18-01421">8</xref>,<xref ref-type="bibr" rid="B9-ijms-18-01421">9</xref>]. As expected, palmitate treatment increased caspase-3 cleavage in cultured mesangial cells (<xref ref-type="fig" rid="ijms-18-01421-f001">Figure 1</xref>A). Moreover, palmitate treatment activated PERK signaling (PERK phosphorylation, eIF2&#x3B1; phosphorylation, and CHOP expression) and ATF6 signaling pathways (ATF6 cleavage) but did not activate the IRE1 signaling pathway (<xref ref-type="fig" rid="ijms-18-01421-f001">Figure 1</xref>B). To confirm whether ER stress signaling activation is linked to mesangial cell apoptosis, mesangial cells were treated with thapsigargin, which triggers ER stress by inhibiting sarcoplasmic/ER Ca<sup>2+</sup>-ATPase (SERCA), leading to Ca<sup>2+</sup> depletion. Thapsigargin treatment increased caspase-3 cleavage, suggesting that ER stress signaling is involved in mesangial cell apoptosis (<xref ref-type="fig" rid="ijms-18-01421-f001">Figure 1</xref>C). To further confirm, we employed the PERK inhibitor GSK2606414, which blocks PERK phosphorylation, and the S1P inhibitor AEBSF, which blocks ATF6 cleavage. As shown in <xref ref-type="fig" rid="ijms-18-01421-f001">Figure 1</xref>D, palmitate-induced caspase-3 cleavage was attenuated by GSK2606414 and AEBSF treatment. In addition, palmitate-induced caspase 3/7 activity and the increased number of apoptotic cells were diminished by treatment with the two inhibitors (<xref ref-type="fig" rid="ijms-18-01421-f001">Figure 1</xref>E,F). These results suggest that lipotoxicity induces mesangial cell apoptosis via PERK and ATF6 signaling pathways.</p>
      </sec>
      <sec id="sec2dot2-ijms-18-01421">
        <title>2.2. PRMT1 Expression Is Increased in Palmitate-Treated Mesangial Cells</title>
        <p>Type I PRMTs, which induce asymmetric dimethyl arginine generation, are closely related to the progression of diabetic nephropathy [<xref ref-type="bibr" rid="B18-ijms-18-01421">18</xref>]. Mesangial cells in the glomerulus are crucial for the maintenance of a normal glomerular filtration rate. Nevertheless, the expression of type I PRMTs in mesangial cells under pathologic conditions has not been explored. Palmitate treatment increased PRMT1 expression, whereas the expression of PRMT3 and PRMT4, which are also type I PRMTs, was not altered (<xref ref-type="fig" rid="ijms-18-01421-f002">Figure 2</xref>A). Immunofluorescence studies also revealed that PRMT1 expression is increased by palmitate treatment and that its expression is observed predominantly in the nuclei of mesangial cells (<xref ref-type="fig" rid="ijms-18-01421-f002">Figure 2</xref>B). Moreover, PRMT1 activity, determined by western blotting using an antibody for ASYM24, which recognizes asymmetrically dimethylated arginine, was elevated by palmitate treatment (<xref ref-type="fig" rid="ijms-18-01421-f002">Figure 2</xref>C).</p>
      </sec>
      <sec id="sec2dot3-ijms-18-01421">
        <title>2.3. PRMT1 Knockdown Attenuates Palmitate-Induced ER Stress Signaling and Mesangial Cell Apoptosis</title>
        <p>To determine whether palmitate-induced ER stress and apoptosis is due to elevated PRMT1 expression, endogenous PRMT1 was silenced by <italic>prmt1</italic> siRNA transfection without the alteration of other type I PRMTs. (<xref ref-type="fig" rid="ijms-18-01421-f003">Figure 3</xref>A). The knockdown of PRMT1 attenuated palmitate-induced ER stress signaling, except for IRE1 phosphorylation (<xref ref-type="fig" rid="ijms-18-01421-f003">Figure 3</xref>B). Moreover, palmitate-induced mesangial cell apoptosis was diminished by <italic>prmt1</italic> siRNA transfection (<xref ref-type="fig" rid="ijms-18-01421-f003">Figure 3</xref>C&#x2013;E). These results suggest that PRMT1 mediates palmitate-induced ER stress activation and mesangial cell apoptosis.</p>
      </sec>
      <sec id="sec2dot4-ijms-18-01421">
        <title>2.4. HFD-Induced Glomerular Apoptosis Is Attenuated in PRMT1 Haploinsufficient Mice</title>
        <p>To confirm in vivo, we investigated the glomeruli of high fat diet (HFD) mice since HFD is known to contribute to intrarenal-lipotoxicity [<xref ref-type="bibr" rid="B8-ijms-18-01421">8</xref>,<xref ref-type="bibr" rid="B19-ijms-18-01421">19</xref>,<xref ref-type="bibr" rid="B20-ijms-18-01421">20</xref>]. We used PRMT1 haploinsufficient (<italic>prmt1</italic><sup>+/&#x2212;</sup>) mice to evaluate the roles of PRMT1 in vivo as PRMT1 knockout mice are embryonically lethal [<xref ref-type="bibr" rid="B21-ijms-18-01421">21</xref>]. The number of apoptotic cells, as determined by a terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay, in the glomerulus was significantly elevated in mice fed HFD for 12 weeks (<xref ref-type="fig" rid="ijms-18-01421-f004">Figure 4</xref>A). However, HFD-induced glomerular apoptosis was significantly attenuated in <italic>prmt1</italic><sup>+/&#x2212;</sup> mice compared with wild-type (WT; <italic>prmt1</italic><sup>+/+</sup>) mice (<xref ref-type="fig" rid="ijms-18-01421-f004">Figure 4</xref>A), implying that PRMT1 could have a significant function in glomerular apoptosis.</p>
      </sec>
    </sec>
    <sec id="sec3-ijms-18-01421" sec-type="discussion">
      <title>3. Discussion</title>
      <p>Lipotoxicity is one of the main causes of worsening DN. However, its precise mechanisms are not fully understood. In the present study, we determined that lipotoxicity-induced mesangial cell apoptosis is due to increased PRMT1 expression. Palmitate treatment significantly increased PRMT1 expression without the alteration of other type I PRMTs (PRMT3 and PRMT4). The subcellular distribution of PRMT1 is known to be cell-type specific. In human osteosarcoma cells (U2OS), PRMT1 was predominantly expressed in the cytoplasm, whereas it was primarily expressed in the nucleus in human breast adenocarcinoma cells (MCF-7) [<xref ref-type="bibr" rid="B22-ijms-18-01421">22</xref>]. Using confocal microscopy, PRMT1 expression was mainly observed in the nucleus of mesangial cells but also slightly in the cytoplasm. This seems to suggest the possibility that PRMT1 acts as a transcriptional cofactor or methylates Histone 2A and Histone 4 to increase the transcription of target genes involved in ER stress and apoptosis in mesangial cells [<xref ref-type="bibr" rid="B23-ijms-18-01421">23</xref>].</p>
      <p>Palmitate-induced ER stress signaling was weakened by the knockdown of PRMT1. This result provides strong evidence that PRMT1 positively regulates ER stress. Recently, Liao et al. reported that PRMT1 can be localized in the ER lumen [<xref ref-type="bibr" rid="B24-ijms-18-01421">24</xref>]. One can imagine that PRMT1 localized in the ER lumen could facilitate PERK phosphorylation and ATF6 cleavage. Further studies should be performed to reveal which part of PRMT1 (nuclear PRMT1 vs. ER lumen PRMT1) plays a role in ER stress signaling activation in mesangial cells.</p>
      <p>In a previous study, we revealed that increased PRMT1 expression is associated with cellular apoptosis in lung epithelial cells and retinal pigment epithelial cells [<xref ref-type="bibr" rid="B25-ijms-18-01421">25</xref>,<xref ref-type="bibr" rid="B26-ijms-18-01421">26</xref>]. However, the roles of PRMT1 in apoptosis in other cells, especially non-tumor cells, were barely explored. The Fukamizu group revealed that the protein kinase B/Akt consensus sites (RxRxxS/T) for the BCL-2 antagonist of cell death (BAD) and Forkhead box O 1 (FOXO1) are methylated by PRMT1 and that methylation at this site competitively inhibits Akt-mediated phosphorylation [<xref ref-type="bibr" rid="B27-ijms-18-01421">27</xref>,<xref ref-type="bibr" rid="B28-ijms-18-01421">28</xref>]. In mesangial cells, the dephosphorylation of the BAD site is known to induce apoptosis [<xref ref-type="bibr" rid="B29-ijms-18-01421">29</xref>]. Therefore, we anticipated that BAD would be a potent substrate of PRMT1 in lipotoxicity-induced mesangial cell apoptosis. However, we could not detect binding between PRMT1 and BAD using an immunoprecipitation assay in mesangial cells (<xref ref-type="app" rid="app1-ijms-18-01421">Figure S1</xref>). In addition, we found that binding between PRMT1 and FOXO1 was unchanged by palmitate treatment in mesangial cells (<xref ref-type="app" rid="app1-ijms-18-01421">Figure S1</xref>). These results imply that PRMT1-mediated mesangial cell apoptosis is probably regulated by a mechanism other than the methylation of BAD and FOXO1. Further studies should be performed to reveal the PRMT1 substrates that induce mesangial cell apoptosis.</p>
      <p>In vivo studies using a PRMT1 haploinsufficient mouse model demonstrated that PRMT1 deficiency confers protective effects against HFD-induced glomerular apoptosis. This confirms that the results from cultured mesangial cells are reproducible in an in vivo animal model. The results from both the cultured cells and the animal model suggest that PRMT1 expression is involved in the progression of diabetic nephropathy.</p>
    </sec>
    <sec id="sec4-ijms-18-01421">
      <title>4. Materials and Methods</title>
      <sec id="sec4dot1-ijms-18-01421">
        <title>4.1. Materials</title>
        <p>Dulbecco&#x2019;s Modified Eagle&#x2019;s Medium (DMEM), Ham&#x2019;s nutrient mixture F-12, and fetal bovine serum (FBS) were purchased from Life Technologies (Gibco BRL, Grand Island, NY, USA). Palmitate and 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF) were obtained from Sigma-Aldrich (St. Louis, MO, USA). The palmitate was prepared as described previously [<xref ref-type="bibr" rid="B30-ijms-18-01421">30</xref>]. Thapsigargin and GSK2606414 were purchased from Millipore (Billerica, MA, USA). p-IRE antibody (ab48187), ATF6 antibody (ab11909), PRMT1 antibody (ab3768), and PRMT4 antibody (ab110024) were purchased from Abcam (Cambridge, UK). caspase-3 antibody (#9662), p-eIF2&#x3B1; antibody (#9721), and CHOP antibody (#2895) were purchased from Cell Signaling Technology (Beverly, MA, USA). ASYM24 antibody (#07-414) was obtained from Millipore. &#x3B2;-actin antibody (sc-1616) and p-PERK antibody (sc-32577-R) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All reagents were of the highest purity commercially available.</p>
      </sec>
      <sec id="sec4dot2-ijms-18-01421">
        <title>4.2. Cell Culture</title>
        <p>The rat mesangial cell line was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were grown in DMEM/Ham&#x2019;s F-12 (1:1) supplemented with 10% fetal bovine serum (FBS) at 37 &#xB0;C in 5% CO<sub>2</sub> in air. Stock cultures of cells were subcultured once a week (split ratio 1:8). Cells were grown to confluence in 60 mm dishes in DMEM/Ham&#x2019;s F-12 with 15 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) buffer, 10% FBS, 5.5 mM glucose, 0.35% additional sodium bicarbonate, 2.5 mM <sc>l</sc>-glutamine, and 1% penicillin/streptomycin at 37 &#xB0;C. The media was changed every other day. Passaged cells were plated to yield near-confluent cultures at the end of the experiments.</p>
      </sec>
      <sec id="sec4dot3-ijms-18-01421">
        <title>4.3. Protein Extraction and Western Blotting</title>
        <p>Cell pellets were lysed in Mammalian Protein Extraction Reagent (M-PER) (Thermo Fisher Scientific, Waltham, MA, USA). Protease inhibitor cocktail (Sigma-Aldrich) and phosphatase inhibitor cocktail I + II (Sigma-Aldrich) were added, and then the proteins were extracted according to the manufacturer&#x2019;s instructions. Western blotting was performed as described previously [<xref ref-type="bibr" rid="B17-ijms-18-01421">17</xref>].</p>
      </sec>
      <sec id="sec4dot4-ijms-18-01421">
        <title>4.4. Caspase-3/7 Activity Assay</title>
        <p>Caspase-3/7 activity was measured with the Caspase-Glo 3/7 Assay Kit (Promega, Madison, WI, USA). Mesangial cells were seeded in a white-walled 96-well plate and then treated with palmitate. After 24 h, the cells were processed according to the manufacture&#x2019;s instruction. GloMax Microplate Reader (Promega) was used for luminescence analysis.</p>
      </sec>
      <sec id="sec4dot5-ijms-18-01421">
        <title>4.5. Annexin V/Propidium Iodide Staining</title>
        <p>Annexin V/Propidium iodide staining was performed with a FITC Annexin V Apoptosis Detection Kit (BD Biosciences, Billerica, MA, USA) according to modified manufacturer&#x2019;s instructions. Mesangial cells cultured in 6-well plates were washed with phosphate-buffered saline (PBS) and then filled with 1 mL of Accutase (Innovative Cell Technologies, San Diego, CA, USA). After two minutes, the plates were gently tapped to detach the cells. The resuspended cells were immediately washed twice with cold PBS and then resuspended in a pre-chilled binding buffer, which contained fluorescein isothiocyanate (FITC)-conjugated annexin V and propidium iodide (PI). After a seven minute incubation on ice in the dark, apoptotic cells were analyzed by flow cytometry (Accuri C6, BD Biosciences). FITC and PI double negative cells (LL; lower-left) were regarded as healthy cells. FITC-positive and PI-negative cells (LR; lower-right) were considered as early apoptotic cells, and FITC and PI double positive cells (UR; upper-right) were late apoptotic cells. FITC-negative and PI positive cells (UL; upper-left) were regarded as necrotic. Apoptotic cells were determined by the sum of early apoptotic cells and late apoptotic cells (LR + UR; red frame).</p>
      </sec>
      <sec id="sec4dot6-ijms-18-01421">
        <title>4.6. Immunofluorescence and Confocal Microscopy</title>
        <p>The cells were washed twice in PBS and fixed for 10 min with 4% paraformaldehyde in PBS. After three washes in PBS, fixed cells were permeabilized with 0.2% Triton X-100. 1% bovine serum albumin (BSA) solution was used for blocking. The cells were incubated with PRMT1 antibody (dilution ratio&#x2014;1:100) for 15 h at 4 &#xB0;C. After three washes in PBS, the cells were incubated with anti-rabbit FITC secondary antibody (Sigma-Aldrich). Then the cells were mounted on slides and the nuclei were visualized with 4&#x2032;,6-diamidino-2-phenylindole (DAPI) present in the ProLong Gold Antifade Mounting Medium (Invitrogen, Carlsbad, CA, USA). Immunofluorescence imaging was performed as described previously [<xref ref-type="bibr" rid="B17-ijms-18-01421">17</xref>].</p>
		</sec>
      <sec id="sec4dot7-ijms-18-01421">
        <title>4.7. siRNA Transfection</title>
        <p>siRNA for PRMT1 (Santa Cruz Biotechnology; sc-41069) and scrambled siRNA (Quiagen, Hilden, Germany) were used for silencing the endogenous PRMT1 expression. 40 nM of each siRNA was transfected into mesangial cells using Lipofectamin&#x2122; RNAiMAX reagent (Invitrogen), following the reverse transfection method, as instructed by the manufacturers.</p>
      </sec>
      <sec id="sec4dot8-ijms-18-01421">
        <title>4.8. Animal Experiments and TUNEL Assay</title>
        <p>Animal experiments were performed in accordance with the &#x201C;Guide for Animal Experiments&#x201D; (Edited by the Korean Academy of Medical Sciences) and approved by the Institutional Animal Care and Use Committee (IACUC) of Seoul National University (SNU121119-3; 19 November 2012). PRMT1 haploinsufficiency mice were kindly provided by Seung-Hoi Koo (Department of Life Science, Korea University, Seoul, Korea). Twelve male C57BL/6J mice were separated into two groups and age matched; six PRMT1 haploinsufficiency mice were one group. The normal diet group was challenged with 10% kcal fat containing feed (Research Diets, NJ, USA; D12450B) and the high fat diet group was challenged with 60% kcal fat containing feed (Research Diets, NJ, USA; D12492) for 12 weeks. After 12 weeks, all the mice were sacrificed and the kidneys were extracted. To make a tissue slide, fixed kidneys in 10% neutral buffered formalin were embedded in paraffin and cut at a 5 &#x3BC;m thickness using a microtome. The kidney sections were deparaffinized with Histochoice, rehydrated with serial diluted ethanol, and washed with distilled water. Staining was performed using the DeadEnd&#x2122; Fluorometric TUNEL System (Promega) according to the manufacturer&#x2019;s instructions. The stained tissues were mounted on slides, and the nuclei were visualized with 4&#x2032;,6-diamidino-2-phenylindole (DAPI) present in the ProLong Gold Antifade Mounting Medium (Invitrogen) and observed using a fluorescence microscope (Eclipse Ni-U, Intensilight C-HGFI, Nikon, Japan).</p>
      </sec>
      <sec id="sec4dot9-ijms-18-01421">
        <title>4.9. Statistical Analysis</title>
        <p>The results were expressed as the mean &#xB1; SEM. Data are representative of three or four independent experiments. For two group comparisons, a student <italic>t</italic> test was used, and for multiple comparisons, one-way ANOVA by SPSS (SPSS Inc., Chicago, IL, USA), followed by the Tukey post hoc test, was used. A value of <italic>p</italic> &lt; 0.05 was considered significant.</p>
      </sec>
    </sec>
    <sec id="sec5-ijms-18-01421" sec-type="conclusions">
      <title>5. Conclusions</title>
      <p>We found that palmitate treatment increases PRMT1 expression. These increases regulate ER stress-mediated mesangial cell apoptosis (<xref ref-type="fig" rid="ijms-18-01421-f004">Figure 4</xref>B). Strategies to decrease PRMT1 expression or reduce its enzymatic activity could be used to prevent the exacerbation of diabetic nephropathy.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="app1-ijms-18-01421">
        <title>Supplementary Materials</title>
        <p>Supplementary materials can be found at <uri>www.mdpi.com/1422-0067/18/7/1421/s1</uri>.</p>
		<supplementary-material id="ijms-18-01421-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ijms-18-01421-s001.pdf"></supplementary-material>
      </app>
    </app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We especially thank Soo-Hyun Park for inspiring and supporting this study. This study was financially supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011141), Rural Development Administration, Korea.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Min-Jung Park, Ho Jae Han, and Dong-il Kim contributed to the planning of the study, the design, and the interpretation of the data; Min-Jung Park and Dong-il Kim collected the data; Min-Jung Park, Ho Jae Han, and Dong-il Kim performed the data analysis; Min-Jung Park and Dong-il Kim drafted the manuscript; Min-Jung Park and Dong-il Kim edited the manuscript; All authors approved the final version of the manuscript.</p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflicts of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-ijms-18-01421">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossing</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>P.K.</given-names>
            </name>
            <name>
              <surname>Hovind</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tarnow</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rossing</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Parving</surname>
              <given-names>H.H.</given-names>
            </name>
          </person-group>
          <article-title>Progression of nephropathy in type 2 diabetic patients</article-title>
          <source>Kidney Int.</source>
          <year>2004</year>
          <volume>66</volume>
          <fpage>1596</fpage>
          <lpage>1605</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00925.x</pub-id>
          <pub-id pub-id-type="pmid">15458456</pub-id>
        </element-citation>
      </ref>
      <ref id="B2-ijms-18-01421">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Bilous</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>El Nahas</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Remuzzi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Piras</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>de Cosmo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Viberti</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Podocyte number in normotensive type 1 diabetic patients with albuminuria</article-title>
          <source>Diabetes</source>
          <year>2002</year>
          <volume>51</volume>
          <fpage>3083</fpage>
          <lpage>3089</lpage>
          <pub-id pub-id-type="doi">10.2337/diabetes.51.10.3083</pub-id>
          <pub-id pub-id-type="pmid">12351451</pub-id>
        </element-citation>
      </ref>
      <ref id="B3-ijms-18-01421">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Mooney</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Savill</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis</article-title>
          <source>J. Clin. Investig.</source>
          <year>1994</year>
          <volume>94</volume>
          <fpage>2105</fpage>
          <lpage>2116</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI117565</pub-id>
          <pub-id pub-id-type="pmid">7962557</pub-id>
        </element-citation>
      </ref>
      <ref id="B4-ijms-18-01421">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qiu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Sublytic C5b-9 triggers glomerular mesangial cell apoptosis via <italic>XAF1</italic> gene activation mediated by p300-dependent IRF-1 acetylation</article-title>
          <source>Cell Death Dis.</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>e1176</fpage>
          <pub-id pub-id-type="doi">10.1038/cddis.2014.153</pub-id>
          <pub-id pub-id-type="pmid">24743731</pub-id>
        </element-citation>
      </ref>
      <ref id="B5-ijms-18-01421">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schena</surname>
              <given-names>F.P.</given-names>
            </name>
            <name>
              <surname>Gesualdo</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Pathogenetic mechanisms of diabetic nephropathy</article-title>
          <source>J. Am. Soc. Nephrol.</source>
          <year>2005</year>
          <volume>16</volume>
          <supplement>(Suppl. S1)</supplement>
          <fpage>S30</fpage>
          <lpage>S33</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2004110970</pub-id>
          <pub-id pub-id-type="pmid">15938030</pub-id>
        </element-citation>
      </ref>
      <ref id="B6-ijms-18-01421">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unger</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.T.</given-names>
            </name>
          </person-group>
          <article-title>Lipotoxicity of &#x3B2;-cells in obesity and in other causes of fatty acid spillover</article-title>
          <source>Diabetes</source>
          <year>2001</year>
          <volume>50</volume>
          <supplement>(Suppl. S1)</supplement>
          <fpage>S118</fpage>
          <lpage>S121</lpage>
          <pub-id pub-id-type="doi">10.2337/diabetes.50.2007.S118</pub-id>
          <pub-id pub-id-type="pmid">11272168</pub-id>
        </element-citation>
      </ref>
      <ref id="B7-ijms-18-01421">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murea</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Parks</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Antinozzi</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Elbein</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Lipotoxicity in diabetic nephropathy: The potential role of fatty acid oxidation</article-title>
          <source>Clin. J. Am. Soc. Nephrol.</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>2373</fpage>
          <lpage>2379</lpage>
          <pub-id pub-id-type="doi">10.2215/CJN.08160910</pub-id>
          <pub-id pub-id-type="pmid">21051750</pub-id>
        </element-citation>
      </ref>
      <ref id="B8-ijms-18-01421">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kume</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Isshiki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Chin-Kanasaki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sugimoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Koya</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Haneda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fenofibrate, a PPAR&#x3B1; agonist, has renoprotective effects in mice by enhancing renal lipolysis</article-title>
          <source>Kidney Int.</source>
          <year>2011</year>
          <volume>79</volume>
          <fpage>871</fpage>
          <lpage>882</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2010.530</pub-id>
          <pub-id pub-id-type="pmid">21270762</pub-id>
        </element-citation>
      </ref>
      <ref id="B9-ijms-18-01421">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mishra</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Simonson</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Saturated free fatty acids and apoptosis in microvascular mesangial cells: Palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G</article-title>
          <source>Cardiovasc. Diabetol.</source>
          <year>2005</year>
          <volume>4</volume>
          <fpage>2</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2840-4-2</pub-id>
          <pub-id pub-id-type="pmid">15642122</pub-id>
        </element-citation>
      </ref>
      <ref id="B10-ijms-18-01421">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katsoulieris</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mabley</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Samai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>P.K.</given-names>
            </name>
          </person-group>
          <article-title>Lipotoxicity in renal proximal tubular cells: Relationship between endoplasmic reticulum stress and oxidative stress pathways</article-title>
          <source>Free Radic Biol. Med.</source>
          <year>2010</year>
          <volume>48</volume>
          <fpage>1654</fpage>
          <lpage>1662</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.03.021</pub-id>
          <pub-id pub-id-type="pmid">20363316</pub-id>
        </element-citation>
      </ref>
      <ref id="B11-ijms-18-01421">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biden</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Boslem</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>K.Y.</given-names>
            </name>
            <name>
              <surname>Sue</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Lipotoxic endoplasmic reticulum stress, &#x3B2; cell failure, and type 2 diabetes mellitus</article-title>
          <source>Trends Endocrinol. Metab.</source>
          <year>2014</year>
          <volume>25</volume>
          <fpage>389</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tem.2014.02.003</pub-id>
          <pub-id pub-id-type="pmid">24656915</pub-id>
        </element-citation>
      </ref>
      <ref id="B12-ijms-18-01421">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malhi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress in liver disease</article-title>
          <source>J. Hepatol.</source>
          <year>2011</year>
          <volume>54</volume>
          <fpage>795</fpage>
          <lpage>809</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jhep.2010.11.005</pub-id>
          <pub-id pub-id-type="pmid">21145844</pub-id>
        </element-citation>
      </ref>
      <ref id="B13-ijms-18-01421">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bedford</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>S.G.</given-names>
            </name>
          </person-group>
          <article-title>Protein arginine methylation in mammals: Who, what, and why</article-title>
          <source>Mol. Cell</source>
          <year>2009</year>
          <volume>33</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2008.12.013</pub-id>
          <pub-id pub-id-type="pmid">19150423</pub-id>
        </element-citation>
      </ref>
      <ref id="B14-ijms-18-01421">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ojima</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ishibashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nishino</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fukami</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamagishi</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression</article-title>
          <source>Am. J. Pathol.</source>
          <year>2013</year>
          <volume>182</volume>
          <fpage>132</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajpath.2012.09.016</pub-id>
          <pub-id pub-id-type="pmid">23159951</pub-id>
        </element-citation>
      </ref>
      <ref id="B15-ijms-18-01421">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>High glucose-induced <italic>O</italic>-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: The possible role in the development of diabetic nephropathy</article-title>
          <source>J. Biol. Chem.</source>
          <year>2014</year>
          <volume>289</volume>
          <fpage>13519</fpage>
          <lpage>13530</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M113.530139</pub-id>
          <pub-id pub-id-type="pmid">24616092</pub-id>
        </element-citation>
      </ref>
      <ref id="B16-ijms-18-01421">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>I.P.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1&#x3B1; regulation in vitro and in vivo</article-title>
          <source>J. Hepatol.</source>
          <year>2014</year>
          <volume>61</volume>
          <fpage>1151</fpage>
          <lpage>1157</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jhep.2014.06.032</pub-id>
          <pub-id pub-id-type="pmid">25003952</pub-id>
        </element-citation>
      </ref>
      <ref id="B17-ijms-18-01421">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>J.I.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Gustafsson</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>PRMT3 regulates hepatic lipogenesis through direct interaction with LXR&#x3B1;</article-title>
          <source>Diabetes</source>
          <year>2015</year>
          <volume>64</volume>
          <fpage>60</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.2337/db13-1394</pub-id>
          <pub-id pub-id-type="pmid">25187371</pub-id>
        </element-citation>
      </ref>
      <ref id="B18-ijms-18-01421">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanhauserova</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Tomandl</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pacal</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kleparnik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Maluskova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bartakova</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Kuricova</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Rehorova</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stepankova</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Svojanovsky</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ADMA, SDMA and <sc>l</sc>-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis</article-title>
          <source>Kidney Blood Press. Res.</source>
          <year>2012</year>
          <volume>36</volume>
          <fpage>200</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="doi">10.1159/000343409</pub-id>
          <pub-id pub-id-type="pmid">23147199</pub-id>
        </element-citation>
      </ref>
      <ref id="B19-ijms-18-01421">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M.Y.</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>Y.S.</given-names>
            </name>
          </person-group>
          <article-title>High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPAR&#x3B1;-FOXO3a-PGC-1&#x3B1; pathway</article-title>
          <source>Nephrol. Dial. Transplant.</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>2213</fpage>
          <lpage>2225</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfr613</pub-id>
          <pub-id pub-id-type="pmid">22076434</pub-id>
        </element-citation>
      </ref>
      <ref id="B20-ijms-18-01421">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-&#x3B1; pathway</article-title>
          <source>Mol. Cell Biochem.</source>
          <year>2015</year>
          <pub-id pub-id-type="doi">10.1007/s11010-015-2576-y</pub-id>
          <pub-id pub-id-type="pmid">26423427</pub-id>
        </element-citation>
      </ref>
      <ref id="B21-ijms-18-01421">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Koo</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Protein arginine methyltransferase 1 regulates hepatic glucose production in a FOXO1-dependent manner</article-title>
          <source>Hepatology</source>
          <year>2012</year>
          <volume>56</volume>
          <fpage>1546</fpage>
          <lpage>1556</lpage>
          <pub-id pub-id-type="doi">10.1002/hep.25809</pub-id>
          <pub-id pub-id-type="pmid">22532369</pub-id>
        </element-citation>
      </ref>
      <ref id="B22-ijms-18-01421">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrmann</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Pably</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Eckerich</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bedford</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Fackelmayer</surname>
              <given-names>F.O.</given-names>
            </name>
          </person-group>
          <article-title>Human protein arginine methyltransferases in vivo&#x2014;Distinct properties of eight canonical members of the PRMT family</article-title>
          <source>J. Cell Sci.</source>
          <year>2009</year>
          <volume>122</volume>
		  <issue>Pt 5</issue>
          <fpage>667</fpage>
          <lpage>677</lpage>
          <pub-id pub-id-type="doi">10.1242/jcs.039933</pub-id>
          <pub-id pub-id-type="pmid">19208762</pub-id>
        </element-citation>
      </ref>
      <ref id="B23-ijms-18-01421">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Lorenzo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bedford</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>Histone arginine methylation</article-title>
          <source>FEBS Lett.</source>
          <year>2011</year>
          <volume>585</volume>
          <fpage>2024</fpage>
          <lpage>2031</lpage>
          <pub-id pub-id-type="doi">10.1016/j.febslet.2010.11.010</pub-id>
          <pub-id pub-id-type="pmid">21074527</pub-id>
        </element-citation>
      </ref>
      <ref id="B24-ijms-18-01421">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liao</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.N.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Arold</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Tsou</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response</article-title>
          <source>J. Clin. Investig.</source>
          <year>2015</year>
          <volume>125</volume>
          <fpage>4529</fpage>
          <pub-id pub-id-type="doi">10.1172/JCI82826</pub-id>
          <pub-id pub-id-type="pmid">26571401</pub-id>
        </element-citation>
      </ref>
      <ref id="B25-ijms-18-01421">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>Y.W.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.U.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Activation of PRMT1 and PRMT5 mediates hypoxia- and ischemia-induced apoptosis in human lung epithelial cells and the lung of miniature pigs: The role of p38 and JNK mitogen-activated protein kinases</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2013</year>
          <volume>440</volume>
          <fpage>707</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.09.136</pub-id>
          <pub-id pub-id-type="pmid">24121109</pub-id>
        </element-citation>
      </ref>
      <ref id="B26-ijms-18-01421">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>I.S.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.Y.</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>PRMT1 and PRMT4 regulate oxidative stress-induced retinal pigment epithelial cell damage in SIRT1-dependent and SIRT1-independent manners</article-title>
          <source>Oxid. Med. Cell. Longev.</source>
          <year>2015</year>
          <volume>2015</volume>
          <elocation-id>617919</elocation-id>
          <pub-id pub-id-type="doi">10.1155/2015/617919</pub-id>
          <pub-id pub-id-type="pmid">26583059</pub-id>
        </element-citation>
      </ref>
      <ref id="B27-ijms-18-01421">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamagata</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Daitoku</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Namiki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hisatake</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kako</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kasuya</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fukamizu</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt</article-title>
          <source>Mol. Cell</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>221</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2008.09.013</pub-id>
          <pub-id pub-id-type="pmid">18951090</pub-id>
        </element-citation>
      </ref>
      <ref id="B28-ijms-18-01421">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakamaki</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Daitoku</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hagiwara</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yamagata</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fukamizu</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2011</year>
          <volume>108</volume>
          <fpage>6085</fpage>
          <lpage>6090</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1015328108</pub-id>
          <pub-id pub-id-type="pmid">21444773</pub-id>
        </element-citation>
      </ref>
      <ref id="B29-ijms-18-01421">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimamura</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Terada</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Okado</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Inoshita</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-&#x3BA;B and BAD</article-title>
          <source>J. Am. Soc. Nephrol.</source>
          <year>2003</year>
          <volume>14</volume>
          <fpage>1427</fpage>
          <lpage>1434</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000066140.99610.32</pub-id>
          <pub-id pub-id-type="pmid">12761242</pub-id>
        </element-citation>
      </ref>
      <ref id="B30-ijms-18-01421">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells</article-title>
          <source>J. Cell Physiol.</source>
          <year>2010</year>
          <volume>225</volume>
          <fpage>654</fpage>
          <lpage>663</lpage>
          <pub-id pub-id-type="doi">10.1002/jcp.22255</pub-id>
          <pub-id pub-id-type="pmid">20506110</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figures</title>
      <fig id="ijms-18-01421-f001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Lipotoxicity induces mesangial cell apoptosis via protein kinase RNA-like endoplasmic reticulum kinase (PERK) and ATF6 signaling pathways. (<bold>A</bold>,<bold>B</bold>) Mesangial cells were treated with 30 &#x3BC;M palmitate for various time intervals. Cell extracts were subjected to western blot analysis with indicated antibodies. The representative immunoblots were from at least three independent experiments; (<bold>C</bold>) mesangial cells were treated with 50 nM thapsigargin for 6 h and 12 h. Cell extracts were subjected to western blot analysis with caspase-3 antibody. The representative immunoblots were from at least three independent experiments; (<bold>D</bold>&#x2013;<bold>F</bold>) mesangial cells were pretreated with 1 &#x3BC;M GSK2606414 or 100 &#x3BC;M AEBSF. After 30 min, cells were treated with 30 &#x3BC;M palmitate for 24 h; (<bold>D</bold>) cell extracts were subjected to western blot analysis with indicated antibodies. The representative immunoblots were from at least three independent experiments; (<bold>E</bold>) caspase 3/7 activity was measured. Data represent the mean &#xB1; SEM of three independent experiments, each performed in triplicate. * <italic>p</italic> &lt; 0.05 vs. control, ** <italic>p</italic> &lt; 0.05 vs. palmitate; (<bold>F</bold>) annexin V and propidium iodide stainings were analyzed. Red frame indicates the sum of early and late apoptotic cells. Representative images were from at least three independent experiments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ijms-18-01421-g001.tif"/>
      </fig>
      <fig id="ijms-18-01421-f002" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Protein arginine methyltransferase 1 (PRMT1) expression is increased in palmitate-treated mesangial cells. (<bold>A</bold>) Mesangial cells were treated with 30 &#x3BC;M palmitate for various time intervals. Type I PRMT expressions were assayed by western blot analysis. The representative immunoblots were from at least three independent experiments. Data represent the means &#xB1; SEM of three independent experiments. * <italic>p</italic> &lt; 0.05 vs. 0 h (ROD: relative optical density); (<bold>B</bold>) mesangial cells were treated with 30 &#x3BC;M palmitate for 24 h. The cells were labeled with anti-PRMT1 and a fluorescein isothiocyanate (FITC)-conjugated secondary antibody. Nuclei were stained with 4&#x2032;,6-diamidino-2-phenylindole (DAPI) and observed under a confocal microscope. The representative images were from at least three independent experiments (scale bar: 5 &#x3BC;m); (<bold>C</bold>) mesangial cells were treated with 30 &#x3BC;M palmitate for 12 h and 24 h. Cell extracts were subjected to western blot analysis with ASYM24 antibody. Representative immunoblots were from at least three independent experiments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ijms-18-01421-g002.tif"/>
      </fig>
      <fig id="ijms-18-01421-f003" position="float">
        <label>Figure 3</label>
        <caption>
          <p>PRMT1 knockdown attenuates palmitate-induced ER stress signaling and mesangial cell apoptosis. (<bold>A</bold>) Mesangial cells were transfected with scramble or PRMT1 siRNA according to the reverse transfection method. After 36 h, cell extracts were subjected to western blot analysis with indicated antibodies. The representative immunoblots were from at least three independent experiments; (<bold>B</bold>&#x2013;<bold>E</bold>) mesangial cells were transfected with scramble or PRMT1 siRNA according to the reverse transfection method. After 24 h, cells were treated with 30 &#x3BC;M palmitate for 24 h; (<bold>B</bold>,<bold>C</bold>) cell extracts were subjected to western blot analysis with indicated antibodies. Representative immunoblots were from at least four independent experiments; (<bold>D</bold>) caspase 3/7 activity was measured. Data represent the mean &#xB1; SEM of three independent experiments, each performed in triplicate. * <italic>p</italic> &lt; 0.05 vs. scramble, ** <italic>p</italic> &lt; 0.05 vs. scramble + palmitate; (<bold>E</bold>) annexin V and propidium iodide stainings were analyzed. Red frame indicates the sum of early apoptotic cells and late apoptotic cells. The representative images were from at least three independent experiments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ijms-18-01421-g003.tif"/>
      </fig>
      <fig id="ijms-18-01421-f004" position="float">
        <label>Figure 4</label>
        <caption>
          <p>High fat diet (HFD)-induced glomerular apoptosis is attenuated in PRMT1 haploinsufficient mice. (<bold>A</bold>) Kidney sections were subjected to terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay as described in &#x201C;Materials and Methods&#x201D;, (scale bar: 20 &#x3BC;M); (<bold>B</bold>) summarized scheme; lipotoxicity-induced PRMT1 exacerbates mesangial cell apoptosis via ER stress.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ijms-18-01421-g004.tif"/>
      </fig>
    </sec>
  </back>
</article>
